Terveystalo Oyj
OMXH:TTALO
Relative Value
The Relative Value of one TTALO stock under the Base Case scenario is 13.93 EUR. Compared to the current market price of 9.35 EUR, Terveystalo Oyj is Undervalued by 33%.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Multiples Across Competitors
TTALO Competitors Multiples
Terveystalo Oyj Competitors
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| FI |
T
|
Terveystalo Oyj
OMXH:TTALO
|
1.2B EUR | 0.9 | 12.4 | 6.6 | 11.3 | |
| US |
|
CVS Health Corp
NYSE:CVS
|
100.6B USD | 0.3 | 56.9 | 14.3 | 14.3 | |
| US |
C
|
Cigna Group
XMUN:CGN
|
71.5B EUR | 0.3 | 13.9 | 8 | 10.2 | |
| US |
|
Cigna Corp
NYSE:CI
|
74B USD | 0.3 | 12.4 | 0 | 0 | |
| DE |
|
Fresenius SE & Co KGaA
XETRA:FRE
|
26.1B EUR | 1.1 | 20.7 | 9.7 | 14.5 | |
| DE |
|
Fresenius Medical Care AG
XMUN:FME
|
22.9B EUR | 1.2 | 23.4 | 9 | 16.7 | |
| US |
|
Laboratory Corporation of America Holdings
NYSE:LH
|
22.7B USD | 1.6 | 25.8 | 12.4 | 18 | |
| US |
|
Quest Diagnostics Inc
NYSE:DGX
|
22.6B USD | 2 | 22.5 | 12.4 | 16.9 | |
| DE |
F
|
Fresenius Medical Care AG & Co KGaA
XETRA:FME
|
11.1B EUR | 0.6 | 11.3 | 5.4 | 10 | |
| US |
|
Guardant Health Inc
NASDAQ:GH
|
12B USD | 12.3 | -29.1 | -31.2 | -28.4 | |
| US |
|
DaVita Inc
NYSE:DVA
|
10.3B USD | 0.8 | 13.8 | 7.2 | 9.8 |